Zhang Meng, Tang Shao-Liang, Yang Tong-Ling, Cheng Yan, Gong Yue
Nanjing University of Chinese Medicine, Nanjing, China.
Nanjing Hospital of TCM, Nanjing, China.
Curr Comput Aided Drug Des. 2025;21(1):110-123. doi: 10.2174/0115734099288156240517114206.
In recent years, the incidence of rectal prolapse has increased significantly due to the sedentary lifestyle and irregular eating habits of modern life. However, there is a lack of clinical studies on the treatment of rectal prolapse with traditional Chinese medicine (TCM) with a large sample size. Therefore, this study investigated the characteristics of rectal prolapse treatment formulas and then studied the network pharmacology of their core therapeutic drugs, which can help to provide a reference for the treatment and postoperative care of rectal prolapse patients.
This study aimed to explore the prescription characteristics and the mechanism of action of core drugs in the treatment of rectal prolapse in Chinese medicine through data mining and bioinformatics techniques.
We collected the diagnosis and treatment information of patients with rectal prolapse from January 2014 to September 2021 in the electronic case database of Nanjing Hospital of TCM, mined the patient information and prescription features using R, screened the active ingredients of the core pairs of drugs and disease drug intersection targets using TCMSP and GnenCard databases, and constructed a Protein-protein interaction (PPI) network using STRING and Cytoscape, and Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses of the intersecting targets were performed using Metascape and R.
We found that prolapse is easy to occur in people over 50 years old, preferably in autumn and winter. Commonly used therapeutic Chinese medicines include and , which are mostly deficiency tonic medicines, warm in nature, and belong to spleen meridian. The core therapeutic medicinal pair was There were 190 common targets of and , and 71 intersection targets of the drug pair and prolapse. The main components of the core drugs for the treatment of prolapse may be quercetin, kaempferol, Stigmasterol, etc, and the core targets may be CASP3, AKT1, HIF1A, etc. The total number of GO entries for the intersection targets of and diseases was 3495, among which the molecular functions accounted for the largest proportion, mainly Pathways in cancer, IL-18 signaling pathway, . KEGG enriched pathway analysis yielded 168 results, and the major pathways were pathways in cancer, lipid and atherosclerosis, IL-17 signaling pathway, etc. Conclusion: This study adopted real-world research methodology and used data mining and bioinformatics technology to mine the medication law of rectal prolapse and its core drug action mechanism from the clinical information of Chinese medicine.
近年来,由于现代生活中久坐的生活方式和不规律的饮食习惯,直肠脱垂的发病率显著增加。然而,缺乏关于中药治疗直肠脱垂的大样本临床研究。因此,本研究调查了直肠脱垂治疗方剂的特点,然后研究了其核心治疗药物的网络药理学,可为直肠脱垂患者的治疗和术后护理提供参考。
本研究旨在通过数据挖掘和生物信息学技术,探索中医治疗直肠脱垂的方剂特点及核心药物的作用机制。
收集南京中医药大学附属医院2014年1月至2021年9月直肠脱垂患者的诊疗信息,利用R语言挖掘患者信息和方剂特征,使用TCMSP和GnenCard数据库筛选核心药物对和疾病-药物交集靶点的活性成分,利用STRING和Cytoscape构建蛋白质-蛋白质相互作用(PPI)网络,并使用Metascape和R对交集靶点进行基因本体(GO)和京都基因与基因组百科全书(KEGG)富集分析。
我们发现脱垂易发生于50岁以上人群,好发于秋冬季节。常用治疗中药包括[具体中药名称1]和[具体中药名称2],多为补虚药,性温,归脾胃经。核心治疗药对为[药对名称]。[药物名称1]和[药物名称2]共有190个共同靶点,药对与脱垂有71个交集靶点。治疗脱垂的核心药物主要成分可能为槲皮素、山奈酚、豆甾醇等,核心靶点可能为CASP3、AKT1、HIF1A等。[药物名称1]与疾病交集靶点的GO条目总数为3495个,其中分子功能占比最大,主要有癌症通路、IL-18信号通路等。KEGG富集通路分析得到168个结果,主要通路有癌症通路、脂质与动脉粥样硬化、IL-17信号通路等。结论:本研究采用真实世界研究方法,利用数据挖掘和生物信息学技术,从中医临床信息中挖掘直肠脱垂的用药规律及其核心药物作用机制。